Search Results 511-520 of 18305 for prostate cancer
The purpose of this study aims to establish a total of 30 new primary prostate cancer cell lines using a portion of biopsy tissue from early-stage prostate ...
The purpose of this study is to clinically test the use of a questionnaire to determine how well it detects differences in knowledge about prostate cancer among ...
"The reality is that prostate cancer is the most commonly diagnosed solid malignancy in men," says Dr. Eugene Kwon, a Mayo Clinic urologist. Dr. Kwon says, ...
People from around the world seek prostate cancer care at Mayo due to its combination of cutting-edge science, compassionate care and strong outcomes. Mayo ...
Biochemically Recurrent Prostate Cancer Detection With Integration of PSMA PET imaging and Extracellular Vesicle-Based Tumor Monitoring · Overview · Participation ...
This also means that 87 out of every 100 men won't develop prostate cancer. Lifetime risk isn't the risk that a person will develop cancer in the next year or ...
Benign prostatic hyperplasia, also called an enlarged prostate, is incredibly common, especially among men over 40. While it's not the same as prostate cancer, ...
... tumor cell. Giving 177Lu-PSMA-617 for 5 cycles versus 6 cycles may better treat patients with metastatic castrate resistant prostate cancer. Participation ...
See a list of publications about prostate cancer by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. Research Profiles. Edit search ...
"Surgery is a common treatment for prostate cancer, especially when we can confirm that the tumor is contained to the prostate. Obviously, physically.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.